Trial Details

Not Recruiting
Basic Information
Clinical ID c2515
Identifier ACTRN12620000741987
Trial Title An Open Label, Multicenter, Observational Study to Assess the Safety, Tolerability and Efficacy of a Pharmaceutical grade Cannabis Medicine (MediCabilis CBD extract Oil) in Patients undergoing Medicinal Cannabis Therapy for Different Indications
Trial URL Visit Original Page
Study Information
Study Results

No results available
Conditions Any approved condition for which MediCabilis has been prescribed for through either Special Access Scheme- Cat B or by an authorised prescriber;Chronic pain;Seizure management/Epilepsy;Post-traumatic stress disorder;Neuropathic pain;Anxiety;Parkinson's disease/Tremor;Dementia;Multiple sclerosis;Insomnia;Inflammatory bowel disease/Irritable bowel syndrome ; Any approved condition for which MediCabilis has been prescribed for through either Special Access Scheme- Cat B or by an authorised prescriber Chronic pain Seizure management/Epilepsy Post-traumatic stress disorder Neuropathic pain Anxiety Parkinson's disease/Tremor Dementia Multiple sclerosis Insomnia Inflammatory bowel disease/Irritable bowel syndrome ;Anaesthesiology - Pain management;Neurological - Epilepsy;Mental Health - Other mental health disorders;Neurological - Other neurological disorders;Neurological - Parkinson's disease;Neurological - Dementias;Neurological - Multiple sclerosis;Oral and Gastrointestinal - Inflammatory bowel disease
Interventions Assess safety, tolerability and efficacy of medicinal cannabis (MediCabilis) being prescribed for any indication. This is a multi-site, observational cohort study, examining the effect of oral cannabidiol in participants receiving MediCabilis for their conditions. Most of the Cannabis Clinics, monitor a range of patient reported outcome and experience measures at defined intervals over the treatment period as part of routine care. This study is designed to collect patient data (demographic, medical history, diagnosis) and also a range of validated patient-reported outcome and experience measures for patients who have received MediCabilis. Patients will be observed for up to 12 months.
Participant Information
Sponsor Bod Australia
City -
Country/Region Australia
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, ELDER, OLDER_ADULT
Study Design
Study Type Observational
Phase Not Available
Time Information
Start Date 2025-04-24
Primary Completion Date 2021-12-01
Completion Date -